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The Editorial on the Research Topic
Transplant Rejection and Tolerance—Advancing the Field through Integration of Computational 
and Experimental Investigation
Seventy years after the first proof of concept that the immune system can be trained to accept 
transplanted tissues via induction of immune tolerance, we are still waiting for a clinical approach 
that could be used routinely in transplant patients. Transplantation is a life-saving surgical proce-
dure that is still only successful when paired with life-long administration of immunosuppressive 
drugs. However, the debilitating side effects of the long-term use of these drugs, together with their 
incomplete control of the immune system, compromise the quality of life and survival of transplant 
recipients. Thus, there is a strong push to find new therapeutic strategies that promote indefinite 
acceptance of a transplanted tissue without compromising the effectiveness of the patient’s immune 
system. Although many exciting ideas have been explored, none of the resulting strategies have been 
successfully converted into a widely applicable therapeutic approach.
Our knowledge of the complex immunological processes leading to transplant rejection contin-
ues to grow, and our understanding of the limitations associated with experimental models deepens. 
There is a great opportunity to foster a different approach to identify novel interventions. New tools 
of genomics, proteomics, and metabolomics are being implemented in powerful analyses that prom-
ise the development of better and safer personalized treatments. In parallel, theoretical modeling is 
slowly but progressively being welcomed among experimentalists due to its ability to unravel relevant 
mechanisms of complex systems and generate new hypotheses (1). The successful employment of 
these promising tools requires effective communication and collaboration among immunologists, 
data-driven modelers, and system biologists.
This Research Topic provides a venue for stimulating these interdisciplinary conversations in the 
context of transplantation. The articles collected under this Research Topic introduce new theoretical 
and experimental studies that describe novel techniques and methods for understanding the interac-
tions between the immune response and transplants and for establishing more effective strategies of 
diagnosis and intervention that will promote transplant tolerance. The contributions of this Research 
Topic can be divided into two main groups according to the approaches they implement: (i) big data 
and bioinformatics and (ii) mechanistic and equation-based models of rejection.
To identify correlations and sensitivities from large data sets, various statistical methods and bio-
informatics approaches are needed. Wang and Sarwal offer a concise review of the current uses and 
advances in statistical approaches and high-dimensional data applications for identifying possible 
transplant biomarkers. Identifying markers of injury, causative markers, and predictive markers is 
key for monitoring, managing patients, and identifying the re-purposing potential of existing drugs. 
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Mastoridis et  al. review current techniques (transcriptomic 
technologies) and propose future ideas for identifying biomark-
ers predictive of tolerance in the context of liver transplantation. 
They also explore how this knowledge could offer great insight 
into studying tolerance to other organs. In their perspective 
article, Stegall and Borrows argue that more accurate and mecha-
nistic mathematical models can be designed to predict (renal) 
allograft loss or chronic injury, but they note that this will require 
access to more detailed molecular, histologic, and serologic data. 
Mechanistic studies conducted in parallel to focused clinical 
trials also would be tremendously useful for understanding why 
grafts fail and for designing tailored intervention.
Several statistical methods are applied to transplant data in 
articles of this collection to identify key biomarkers. Pike et  al. 
used principle component analysis and other tools to analyze a 
large set of T cell immunophenotyping data before and after renal 
transplantation. They discovered that pretransplant frequency of 
programmed death 1 (PD-1) expressing T  cell subsets stratifies 
patients at risk of developing rejection episodes. In a study of 
kidney transplants, Kadota et al. used various statistical algorithms 
to analyze the transcriptome of allograft biopsies and showed that 
histological classification of T  cell mediated rejection contains 
multiple subtypes of rejection amenable to more personalized 
treatments. When studying the inflammatory response associated 
with ischemic injury, Starzl et al. combined principal component 
analysis and a regression approach to discover a cytokine-based sig-
nature to define the type and severity of the inflammatory response.
In transplant modeling, identifying the key players and inter-
actions between transplants and the immune system is critical to 
understanding the pathway to rejection or tolerance. An agent-
based model presented by An provides a dynamic and mechanistic 
understanding of transplant immunology so that control strategies 
to induce tolerance can be built. Arciero et al. provide one of the first 
comprehensive mathematical models of mouse heart transplant 
rejection. This ordinary differential equation-based model tracks 
innate and adaptive immunity and provides important suggestions 
of new investigations to improve the understanding of rejection. 
Day et al. present an ordinary differential equation model focused 
on the inflammatory response to surgical and ischemia/reperfu-
sion injury. The model predicts specific conditions that lead to 
tolerance and others that lead to an exaggerated rejection response. 
Best et al. use a computational model of T cell repertoire develop-
ment to examine self/non-self discrimination when incorporating 
features of cross-reactivity and T cell cooperativity. The resulting 
dynamic state of tolerance suggests specific opportunities for 
therapeutic intervention to achieve long-term tolerance.
Overall, all of the contributions to this Research Topic high-
light the still largely untapped potential of integrating data-driven 
and mechanistic modeling into the “ordinary” experimental 
scientific approach to address key questions of transplant immu-
nology in academic settings. As noted at a recent workshop of 
computational and experimental immunologists convened by the 
NIAID (2), there is still a broad divergence among researchers 
on how to approach fundamental immunological questions. 
This separation between modelers and experimentalists is even 
deeper in transplant immunology. However, all researchers share 
the common goal of improving the life of transplanted patients 
by understanding how to predict the behavior of immunologi-
cal responses underlying graft rejection and failure. Despite the 
continuous growth of technological advances, it is still difficult 
to predict how a certain molecular or cellular intervention will 
affect the behavior of the entire system over time. This could be 
achieved, however, by properly integrating experimentation, data-
driven modeling, and mechanistic modeling to test non-intuitive 
conditions impractical to explore using experimentation alone. 
The close collaboration between experimentalists and modelers 
necessary to reach this result requires a novel component of for-
mal training of each part that will lead to productive communica-
tion and work integration. This Research Topic encourages the 
research community to embrace and implement this approach 
and witness exciting new discoveries that will ultimately benefit 
the patient population.
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